NCT05958927

Brief Summary

Gestational diabetes mellitus is associated with abnormal blood sugar levels throughout pregnancy in women without prior diabetes. Many studies have been conducted on the relationship between diabetes and oxidative stress. In this study, it was aimed to investigate the presence of fundus findings in patients with gestational diabetes and/or impaired blood sugar based on the results of previous studies and to simultaneously investigate the thiol-disulfide homeostasis in the tears of the patients.There was no previous study in the literature on thiol disulfide homeostasis in tears in gestational diabetic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 13, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 3, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 25, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2024

Completed
1 year until next milestone

Results Posted

Study results publicly available

February 27, 2025

Completed
Last Updated

March 10, 2025

Status Verified

February 1, 2025

Enrollment Period

10 months

First QC Date

July 3, 2023

Results QC Date

February 17, 2024

Last Update Submit

February 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DM

    All patients underwent a 50-g GTT at any time of the day. Women with ≥ 140 mg/dL on the 50-g GTT in the first hour but with a normal 100-g oral GTT level were included in the hyperglycemia group. Women with a 50-g GTT level \< 140 mg/dL were categorized as normal and included in the control group

    26 weeks of pregnant

Secondary Outcomes (3)

  • Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM

    26 weeks pregnant women

  • Oxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DM

    26 weeks of pregnant

  • Retinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM

    26 weeks of pregnant

Study Arms (2)

Control group

Non diabetic women

Other: tear test and eye measurement

Case group

Women with impairment glucose status

Other: tear test and eye measurement

Interventions

tear test and eye measurement

Case groupControl group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

A total of 60 pregnant women participated in the study. (30 gestational diabetes and/or impaired blood sugar and 30 healthy pregnant women).

You may qualify if:

  • Healthy pregnant at 24-28 weeks of pregnancy
  • Pregnant patients diagnosed with gestational diabetes and/or impaired blood sugar at 24-28 weeks of pregnancy

You may not qualify if:

  • Type 1diabetes mellitus,
  • Type 2 diabetes mellitus,
  • Patient that history of ocular surface disease,
  • Topical/systemic medical therapy with ocular inflamatuar disease such as üveitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Usak University Medical Faculty

Uşak, 64000, Turkey (Türkiye)

Location

Related Publications (4)

  • Rask-Madsen C, King GL. Kidney complications: factors that protect the diabetic vasculature. Nat Med. 2010 Jan;16(1):40-1. doi: 10.1038/nm0110-40. No abstract available.

    PMID: 20057426BACKGROUND
  • Barbour LA. New concepts in insulin resistance of pregnancy and gestational diabetes: long-term implications for mother and offspring. J Obstet Gynaecol. 2003 Sep;23(5):545-9. doi: 10.1080/0144361031000156500. No abstract available.

    PMID: 12963518BACKGROUND
  • Karacay O, Sepici-Dincel A, Karcaaltincaba D, Sahin D, Yalvac S, Akyol M, Kandemir O, Altan N. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res Clin Pract. 2010 Sep;89(3):231-8. doi: 10.1016/j.diabres.2010.04.015.

    PMID: 20537747BACKGROUND
  • Lopez-Tinoco C, Roca M, Garcia-Valero A, Murri M, Tinahones FJ, Segundo C, Bartha JL, Aguilar-Diosdado M. Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus. Acta Diabetol. 2013 Apr;50(2):201-8. doi: 10.1007/s00592-011-0264-2. Epub 2011 Feb 17.

    PMID: 21327985BACKGROUND

MeSH Terms

Conditions

Diabetes, GestationalEye DiseasesRetinal Diseases

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Results Point of Contact

Title
Suzan Doğruya
Organization
Usak University Medical Faculty

Study Officials

  • Suzan Doğruya

    Usak University Medical Faculty

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

July 3, 2023

First Posted

July 25, 2023

Study Start

April 13, 2023

Primary Completion

February 17, 2024

Study Completion

February 17, 2024

Last Updated

March 10, 2025

Results First Posted

February 27, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations